Rockefeller Capital Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-200
| Closed | – | – | 4017 |
|
|
2022
Q3 | $0 | Sell |
200
-1,041
| -84% | – | ﹤0.01% | 4094 |
|
|
2022
Q2 | $3K | Buy |
1,241
+1,041
| +521% | +$2.52K | ﹤0.01% | 3650 |
|
|
2022
Q1 | $1K | Hold |
200
| – | – | ﹤0.01% | 3738 |
|
|
2021
Q4 | $1K | Sell |
200
-900
| -82% | -$4.5K | ﹤0.01% | 3649 |
|
|
2021
Q3 | $11K | Sell |
1,100
-110
| -9% | -$1.1K | ﹤0.01% | 2849 |
|
|
2021
Q2 | $18K | Hold |
1,210
| – | – | ﹤0.01% | 2529 |
|
|
2021
Q1 | $19K | Buy |
1,210
+1,010
| +505% | +$15.9K | ﹤0.01% | 2303 |
|
|
2020
Q4 | $4K | Hold |
200
| – | – | ﹤0.01% | 2491 |
|
|
2020
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 2413 |
|
|
2020
Q2 | $3K | Hold |
200
| – | – | ﹤0.01% | 2226 |
|
|
2020
Q1 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 2178 |
|